Cision PR Newswire
Adela’s tissue-agnostic MRD test has been clinically validated to predict and surveil for recurrence in patients with head & neck cancer, regardless o... Read more.
NEW YORK, Sept. 14, 2024 /PRNewswire/ — International menswear brand Coofandy and women’s sleepwear label Ekouaer made a bold entrance at New York F... Read more.
In Phase Ia clinical study, GZR4 demonstrated favorable safety and tolerability profiles in healthy subjects, maintaining a stable glucose-lowering effect for u... Read more.
CHENGDU, China, Sept. 14, 2024 /PRNewswire/ — With cross-border trade representing a new direction for e-commerce in recent years, cross-border e-commerce... Read more.
ANAHEIM, Calif., Sept. 14, 2024 /PRNewswire/ — At RE+ 2024, Sunwoda made a significant impact under the theme “Sunwoda Inside,” underscoring ... Read more.
HANOI, Vietnam, Sept. 14, 2024 /PRNewswire/ — Mox Capital, a trailblazer in alternative investments with AUM of US$1.4 billion, is announcing its strategi... Read more.
Updated Phase 1 dose-escalation data from ARROS-1 and ALKOVE-1 clinical trials continue to support potential best-in-class profiles for zidesamtinib and NVL-655... Read more.
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Sept. 14, 2024 /PRNewswire/ — Harbour BioMed (the “Company”; HKEX: 02142), a glob... Read more.
PASAY CITY, Philippines, Sept. 14, 2024 /PRNewswire/ — TIME Magazine and Statista have recognized SM Investments Corporation, SM Prime Holdings, and Chin... Read more.
SAN JOSE, Calif., Sept. 14, 2024 /PRNewswire/ — From September 10-12, 2024, MSquare Technology made a standout appearance at the highly anticipated AI H... Read more.